Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,940,329
+$3,010,720 QoQ
Shares Held
148,386
+2.3% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
1.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 79.00947528742603.ToString("F0")%
Shared 0.ToString("F0")%
None 20.99052471257396.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $211,400,940 across 22 Biotechnology names. ASND ranks #2 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
283,567 | $56,614,151 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
148,386 | $33,940,329 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
898,611 | $17,576,831 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
617,489 | $13,745,305 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
147,037 | $13,583,278 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
770,711 | $11,144,481 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
1,944,671 | $8,692,679 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
487,898 | $7,230,648 |
All Filings in ASND
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,940,329 | 148,386 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,929,609 | 145,046 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,242,962 | 147,090 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $27,634,986 | 160,110 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $25,061,664 | 160,796 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $22,562,460 | 163,888 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $23,981,276 | 160,614 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $20,682,845 | 151,656 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $24,551,822 | 162,412 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $21,270,813 | 168,883 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $15,898,854 | 169,787 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $15,481,572 | 173,463 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $16,611,380 | 154,928 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,799,104 | 145,739 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $14,089,310 | 136,445 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $15,151,364 | 162,988 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $15,831,864 | 134,900 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $13,434,300 | 99,861 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,235,732 | 76,766 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,284,758 | 40,173 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $5,177,496 | 40,173 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,001,924 | 41,983 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,439,329 | 22,287 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||